腾讯押注，AI医疗龙头森亿医疗寻求赴港上市

Core Viewpoint - Shanghai Senyi Medical Technology Co., Ltd., an AI medical solution provider backed by Tencent, is planning to list on the Hong Kong Stock Exchange under special technology company regulations due to its ongoing net losses and inability to meet standard listing requirements [1]. Company Overview - Founded in 2016, Senyi Medical is the only AI medical company globally that offers a full range of solutions from Level 1 to Level 4, showcasing its comprehensive technical development capabilities [4]. - As of June 30, 2025, the company has served over 750 hospitals, including more than 400 large hospitals, and has successfully launched its first AI-driven clinic pilot project in Saudi Arabia [5]. Financial Performance - The company has recorded continuous net losses since its inception. Revenue figures from 2022 to 2024 are projected at RMB 144 million, RMB 239 million, and RMB 292 million, with corresponding losses of RMB 376 million, RMB 352 million, and RMB 207 million [6]. - For the first half of 2025, revenue reached RMB 112 million, a year-on-year increase of 23.34%, while the loss was RMB 97.5 million, compared to a loss of RMB 103 million in the same period the previous year [6]. Shareholding Structure - The founding team holds approximately 30.58% of the shares prior to the IPO, with significant investments from Tencent and other institutional investors [9][14].